Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Taysha Gene Therapies Inc (NASDAQ: TSHA) was $2.21 for the day, down -7.53% from the previous closing price of $2.39. In other words, the price has decreased by -$7.53 from its previous closing price. On the day, 6.72 million shares were traded. TSHA stock price reached its highest trading level at $2.53 during the session, while it also had its lowest trading level at $2.17.
Ratios:
Our analysis of TSHA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Manning Paul B bought 100,000 shares of TSHA for $163,000 on Nov 17 ’23. The 10% Owner now owns 16,566,667 shares after completing the transaction at $1.63 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 452924064 and an Enterprise Value of 338484704. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.19 while its Price-to-Book (P/B) ratio in mrq is 4.09. Its current Enterprise Value per Revenue stands at 26.294 whereas that against EBITDA is -4.47.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is 11.84%, while the 200-Day Moving Average is calculated to be -7.68%.
Shares Statistics:
TSHA traded an average of 2.57M shares per day over the past three months and 8217870 shares per day over the past ten days. A total of 186.96M shares are outstanding, with a floating share count of 158.49M. Insiders hold about 22.67% of the company’s shares, while institutions hold 72.37% stake in the company. Shares short for TSHA as of 1730332800 were 17637427 with a Short Ratio of 6.85, compared to 1727654400 on 20644679. Therefore, it implies a Short% of Shares Outstanding of 17637427 and a Short% of Float of 11.359999.
